FDA recalls QuickVue strep test over false-positive concerns
The FDA has posted a Class II recall for specific lots of the QuickVue Dipstick Strep A Test. The action matters because rapid strep tests help guide next steps for sore throats, and a negative result is not always the final word — especially in children and teens with symptoms.
The FDA has posted a Class II recall for specific lots of the QuickVue Dipstick Strep A Test because the product was associated with potential false positive results. For families, clinics, and schools that rely on rapid strep testing to help sort out a sore throat, that means test results need to be interpreted in context.
The recall is limited to specific lots, not every QuickVue strep test. CDC guidance also says a negative rapid strep test in symptomatic children and teens should be followed by a throat culture, while adults usually do not need that extra step.
What the recall covers
According to the FDA recall record, the action applies to QuickVue Dipstick Strep A Test, 50T, REF 20108, with lot numbers 225788, 228322, and 233274. The FDA posted the recall on May 12, 2026, and lists it as a Class II recall. The firm told customers to stop using, render unusable, and discard remaining inventory from the affected lots.
The FDA also says the recall is tied to specific inventory distributed in the United States. That means most patients will not be affected directly unless a clinic used one of the listed lots.
Why this matters for sore-throat care
Rapid strep tests are used to help determine whether group A strep bacteria are likely causing a sore throat or rash. CDC guidance says these tests are fast, while a throat culture takes longer but can find infections the rapid test misses. That distinction matters because untreated strep can lead to complications, and it can also affect whether antibiotics are started.
MedlinePlus notes that if a rapid strep test is negative but a clinician still suspects strep throat, a throat culture may be ordered. It also explains that throat culture is more accurate, though it takes longer to return results.
What CDC says about a negative test
CDC guidance is clear that children age 3 and older who have symptoms of strep throat should have a throat culture after a negative rapid antigen test. For adults, CDC says a follow-up culture is usually not necessary after a negative rapid test.
That does not mean every sore throat is strep. CDC also notes that many illnesses can cause pharyngitis, and people with clear viral symptoms do not usually need strep testing in the first place.
What patients and parents can do now
If a child or adult recently had a rapid strep test, ask the clinic whether the test came from any affected QuickVue lots. If symptoms are not improving, or if a clinician still suspects strep despite a negative rapid test, ask whether a throat culture or other follow-up is needed.
Get urgent care for severe trouble breathing, inability to swallow fluids, signs of dehydration, or a rapidly worsening illness. For routine sore throat questions, a primary care clinician, urgent care clinic, or pediatrician can help interpret results in context.
What clinics should do
Clinics and laboratories should stop using the affected lots, discard remaining inventory, and follow the recall notice’s documentation steps. The FDA says QuidelOrtho asked customers to return confirmation of receipt and to review the notice with their medical director.
Facilities that distributed the affected product should also forward the recall notice to downstream customers, according to the FDA record.
Bottom line
The immediate risk is limited to specific test lots, but the broader lesson is important: a rapid strep result should be interpreted alongside symptoms and follow-up guidance. That is especially true in children and teens with symptoms that still fit strep throat.
Sources
Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.
This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.
